Technology

Mylan Technologies Inc. (MTI) continues to be on the cutting edge of transdermal technology. Our highly trained scientists, engineers and operations specialists work to create the transdermal technology of tomorrow.

We also formulate and manufacture the components required in the composition of TDDS patches: films, laminates, adhesives, backings and release liners. This, combined with the strength of the Mylan family, gives us a tremendous advantage in the development and distribution of transdermal products. MTI's formulation and product development teams have successfully developed ANDA and NDA products that include matrices based upon dispersions, solutions or emulsions. We have expertise in transdermal penetration enhancers and crystal inhibitors, and have been able to achieve target drug delivery profiles. This includes transdermal products that meet adhesive/product use requirements of 12 hours to 7 days.

Patented TDDS Technology Only From MTI
MTI's concentrated involvement in the development of Transdermal Drug Delivery Systems (TDDS) has generated a family of patch designs and constructions covered by U.S. and international patents.
MTI's assortment of process and product patents allows us to make a wide array of TDDS patches.